We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Walgreens Boots Alliance (WBA) Outpaced the Stock Market Today
Read MoreHide Full Article
Walgreens Boots Alliance (WBA - Free Report) closed at $11.16 in the latest trading session, marking a +0.95% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of 0.58%. Meanwhile, the Dow experienced a rise of 0.62%, and the technology-dominated Nasdaq saw an increase of 1.07%.
The the stock of largest U.S. drugstore chain has risen by 2.5% in the past month, lagging the Retail-Wholesale sector's gain of 10.56% and the S&P 500's gain of 11.33%.
The investment community will be paying close attention to the earnings performance of Walgreens Boots Alliance in its upcoming release. In that report, analysts expect Walgreens Boots Alliance to post earnings of $0.34 per share. This would mark a year-over-year decline of 46.03%. At the same time, our most recent consensus estimate is projecting a revenue of $36.66 billion, reflecting a 0.85% rise from the equivalent quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.66 per share and revenue of $151.49 billion. These totals would mark changes of -42.36% and +2.59%, respectively, from last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Walgreens Boots Alliance. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, there's been a 3.25% rise in the Zacks Consensus EPS estimate. Walgreens Boots Alliance is holding a Zacks Rank of #3 (Hold) right now.
In terms of valuation, Walgreens Boots Alliance is currently trading at a Forward P/E ratio of 6.65. This valuation marks a premium compared to its industry's average Forward P/E of 5.11.
Investors should also note that WBA has a PEG ratio of 1.33 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Retail - Pharmacies and Drug Stores industry had an average PEG ratio of 0.77 as trading concluded yesterday.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry, currently bearing a Zacks Industry Rank of 4, finds itself in the top 2% echelons of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Walgreens Boots Alliance (WBA) Outpaced the Stock Market Today
Walgreens Boots Alliance (WBA - Free Report) closed at $11.16 in the latest trading session, marking a +0.95% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of 0.58%. Meanwhile, the Dow experienced a rise of 0.62%, and the technology-dominated Nasdaq saw an increase of 1.07%.
The the stock of largest U.S. drugstore chain has risen by 2.5% in the past month, lagging the Retail-Wholesale sector's gain of 10.56% and the S&P 500's gain of 11.33%.
The investment community will be paying close attention to the earnings performance of Walgreens Boots Alliance in its upcoming release. In that report, analysts expect Walgreens Boots Alliance to post earnings of $0.34 per share. This would mark a year-over-year decline of 46.03%. At the same time, our most recent consensus estimate is projecting a revenue of $36.66 billion, reflecting a 0.85% rise from the equivalent quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.66 per share and revenue of $151.49 billion. These totals would mark changes of -42.36% and +2.59%, respectively, from last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Walgreens Boots Alliance. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, there's been a 3.25% rise in the Zacks Consensus EPS estimate. Walgreens Boots Alliance is holding a Zacks Rank of #3 (Hold) right now.
In terms of valuation, Walgreens Boots Alliance is currently trading at a Forward P/E ratio of 6.65. This valuation marks a premium compared to its industry's average Forward P/E of 5.11.
Investors should also note that WBA has a PEG ratio of 1.33 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Retail - Pharmacies and Drug Stores industry had an average PEG ratio of 0.77 as trading concluded yesterday.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry, currently bearing a Zacks Industry Rank of 4, finds itself in the top 2% echelons of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.